Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Comment by Sarb99on Feb 12, 2021 3:49am
131 Views
Post# 32549509

RE:RE:RE:RE:RE:Yes I agree, if you have a Question ask the management

RE:RE:RE:RE:RE:Yes I agree, if you have a Question ask the management
Sure, that is fine. In my opinion, if they explained everything to me in an email whether it is positive or negative. That probably gives me the advantage to buy or sell, based on that information. 
 
I think ethically another press release is much better, so everyone gets the same information at the same time. 

CerealKiller wrote:
Sarb99 wrote:
Can you please explain, how is this weak response? All they said in the message was more information to follow. I don't think, they are going to explain everything to me in an email. What I got from the message was, they will issue follow-up news Friday or Monday explaining. If they don't then I can send them an email again with my follow up questions. 
 
I know it is a lot of money, but I am not going to lash out at them without hearing them first. We need to see follow-up news to see if we get more information and it explains. Yes, we as shareholders can ask them the questions, if not satisfied. I am the kind of guy, I will sell and move on. In my opinion, Medivolve is much more than 20 million shares. If you think otherwise then you need to decide, what you want to do with your holding. 
 
You say "As far as Shelburn goes, it's a bit disingenuous to write him off" ok can you tell me what other option you, I or the company have? Yes, Medivolve promised more collection sites than currently in operation. Honestly, I am still ok, if all 126 collection sites are up and running in the next 3-4 weeks generating $30-$35 million per month. 
 
You can see this as you like a glass half empty or half full. 

CerealKiller wrote: Whoops. Posting problem. Again: I don't know, man. That's a very weak response you got from management and 20 million shares is currently worth roughly $8 million? That's a heck of a lot of money and a serious investment for something that nobody can find anything about. Aa far as Shelburn goes, it's a bit disingenuous to write him off as just an employee and how anyone below him can easily take over. Besides, if he's so easily replaceable and already not meeting goals, that's another huge problem unto itself. Ugh.

 


Sure I can explain how it was a weak response. IMMEDIATELY after this news was announced, there was a sudden and growing uproar across Stockhouse, ceo.ca, stockwits, and Reddit. It was so swift and everyone was asking the same thing, "Who/Whit is Karland?" A response of "More information to come" is rather dismissive in its vagueness and with the SP immediately tanking after to not release that information right as soon as possible is irresponsible, especially if there is nothing fishy about this company and even its mere existence. As it is, it could look like to many that management is trying to figure out a narrative, rather than just releasing factual information. Now, I'm NOT saying that is what is happening, but it's understandale that many might see it that way.

Besides, let's be real for a mintue... Are we to believe that management/Sommerville wasn't astute enough to realize that questions wouldn't be asked about Karland? Are we to believe that they thought we would just go, "Oh, OK, great" and not do any reasearch, or even just a quick Google search. I find it hard to believe that they would believe that, and if so, that's shocking. So if they don't believe that, then for them to release this news with zero tangible information about the company is dismissive of us. So, yeah, I am going to stand by my asseriton that this was a "weak response".

Your statement that Medivolve is a lot more than 20 million shares is true, of course, I never said otherwise. So to insinuate that if I believe this (again, I never said I do) I should sell and move on, ala so many other disingenuous responses from other posters when somoene isn't blindly following/pumping, well, Sarb, that's beneath you. It is. 

And then there's Shelburn. You're right that there's no better alternative. But to abdicate the company of blame for putting him into that position is just sweeping a mistake under the rug.

And that's the thing... a short while ago there were no real red flags. Then the share price started plummeting. Then there's a mystery company that no one has heard of or can find even a single digital footprint about getting 20 million shares. Then there are the negative reviews on Google Maps (this is true - it's not just a knowsbest bashing thing). Then there is Shelburn. A lot of stuff is adding up quickly and Medivolve seems completely disinterested in doing damage control, never mind anticipating problems and being proactive rather than reactice.

Look, we're on the same side even if our tones are vastly different. I expect more transparency and accountability to shareholders though. Let's hope, for your investment, my investment and others' investments (Yes, even lying Hiddensecrets) that they're just indifferent to sharehoilders' concerns but good at their jobs in other areas becaise the alernative is very frightening.



<< Previous
Bullboard Posts
Next >>